BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:17 PM
 | 
Sep 28, 2012
 |  BC Extra  |  Politics & Policy

FDA issues guidance on antibiotics for cIAI

FDA issued draft guidance on the development of drugs to treat complicated intra-abdominal infection (cIAI). The agency recommended the use of active-controlled, non-inferiority Phase III trials for patients for whom an effective therapy is already available. In patients who have limited treatment options, such as those who are intolerant to marketed drugs...

Read the full 243 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >